Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Emilia Roy-Vallejo"'
Autor:
Pedro Martínez-Fleta, Esther F. Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P. Mejía-Abril, Jesús A. García-Vadillo, Irene Llorente-Cubas, José R. Villagrasa, José M. Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Álvaro, Santos Castañeda
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract B and T cell responses were evaluated in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) after 1 or 2 weeks of methotrexate (MTX) withdrawal following each COVID-19 vaccine dose and compared with those who maintained MTX
Externí odkaz:
https://doaj.org/article/68cb81a827cf4cafad508bc550296c46
Autor:
Emilia Roy-Vallejo, Sara Fernández De Córdoba-Oñate, Pablo Delgado-Wicke, Ana Triguero-Martínez, Nuria Montes, Rosa Carracedo-Rodríguez, Nelly Zurita-Cruz, Ana Marcos-Jiménez, Amalia Lamana, José María Galván-Román, Gonzalo Villapalos García, Pablo Zubiaur, Marianela Ciudad, Laura Rabes, Marta Sanz, Carlos Rodríguez, Almudena Villa, Jesús Álvarez Rodríguez, Celeste Marcos, Julia Hernando, Paula Díaz-Fernández, Francisco Abad, Ignacio de los Santos, Diego A. Rodríguez Serrano, Rosario García-Vicuña, Carmen Suárez Fernández, Rosa P. Gomariz, Cecilia Muñoz-Calleja, Elena Fernández-Ruiz, Isidoro González-Álvaro, Laura Cardeñoso, the PREDINMUN-COVID Group
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionSARS-CoV-2 viral load has been related to COVID-19 severity. The main aim of this study was to evaluate the relationship between SARS-CoV-2 viremia and SNPs in genes previously studied by our group as predictors of COVID-19 severity.Mater
Externí odkaz:
https://doaj.org/article/8ca2939964894199a76694e0185eb3b7
Autor:
Alba Antequera, M. Ana Cuadrado-Conde, Emilia Roy-Vallejo, María Montoya-Martínez, Montserrat León-García, Olaya Madrid-Pascual, Sara Calderón-Larrañaga, on behalf of Research for gender equity collaboration
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-8 (2022)
Abstract Background Sex-specific analysis and reporting may allow a better understanding of intervention effects and can support the decision-making process. Well-conducted systematic reviews (SRs), like those carried out by the Cochrane Collaboratio
Externí odkaz:
https://doaj.org/article/896fe526935f4f1db07e3b382ad04fc9
Autor:
Laura Rabes, Laura Adán-Lirola, María del Pilar González-Molina, José María Galván-Román, Fernando Moldenhauer, Emilia Roy-Vallejo, Diego Real de Asúa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract To describe congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome (DS), which could inform potential health recommendations for this population. Cross-sectional, observational study of adults with DS evaluat
Externí odkaz:
https://doaj.org/article/fc084a4c5ce24cf7ba3246a71cc2e3b8
Autor:
Diego A. Rodríguez-Serrano, Emilia Roy-Vallejo, Nelly D. Zurita Cruz, Alexandra Martín Ramírez, Sebastián C. Rodríguez-García, Nuria Arevalillo-Fernández, José María Galván-Román, Leticia Fontán García-Rodrigo, Lorena Vega-Piris, Marta Chicot Llano, David Arribas Méndez, Begoña González de Marcos, Julia Hernando Santos, Ana Sánchez Azofra, Elena Ávalos Pérez-Urria, Pablo Rodriguez-Cortes, Laura Esparcia, Ana Marcos-Jimenez, Santiago Sánchez-Alonso, Irene Llorente, Joan Soriano, Carmen Suárez Fernández, Rosario García-Vicuña, Julio Ancochea, Jesús Sanz, Cecilia Muñoz-Calleja, Rafael de la Cámara, Alfonso Canabal Berlanga, Isidoro González-Álvaro, Laura Cardeñoso, the REINMUN-COVID Group
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retr
Externí odkaz:
https://doaj.org/article/97c9df8d7dbb43738740dce63bc7937c
Autor:
Emilia Roy-Vallejo, Laura Cardeñoso, Ana Triguero-Martínez, Marta Chicot Llano, Nelly Zurita, Elena Ávalos, Ana Barrios, Julia Hernando, Javier Ortiz, Sebastián C. Rodríguez-García, Marianela Ciudad Sañudo, Celeste Marcos, Elena García Castillo, Leticia Fontán García-Rodrigo, Begoña González, Rosa Méndez, Isabel Iturrate, Ancor Sanz-García, Almudena Villa, Ana Sánchez-Azofra, Begoña Quicios, David Arribas, Jesús Álvarez Rodríguez, Pablo Patiño, Marina Trigueros, Miren Uriarte, Alexandra Martín-Ramírez, Cristina Arévalo Román, José María Galván-Román, Rosario García-Vicuña, Julio Ancochea, Cecilia Muñoz-Calleja, Elena Fernández-Ruiz, Rafael de la Cámara, Carmen Suárez Fernández, Isidoro González-Álvaro, Diego A. Rodríguez-Serrano, the PREDINMUN-COVID Group, Jesús Sanz, Pedro Casado, Ángela Gutiérrez, Azucena Bautista, Pilar Hernández, Nuria Ruiz Giménez, Berta Moyano, Paloma Gil, María Jesús Delgado, Pedro Parra, Beatriz Sánchez, Carmen Sáez, Marta Fernández Rico, Diego Domingo García, Teresa Alarcón Cavero, María Auxiliadora Semiglia Chong, Ainhoa Gutiérrez Cobos, Santos Castañeda, Irene Llorente, Eva G. Tomero, Noelia García Castañeda, Nuria Montes, Cristina Dominguez Peña, David Jiménez Jiménez, Pablo Villamayor, Alfonso Canabal, Tamara Alonso, Carolina Cisneros, Claudia Valenzuela, Francisco Javier García Pérez, Rosa María Girón, Javier Aspa, M. del Perpetuo Socorro Churruca, Enrique Zamora, Adrián Martínez, Mar Barrio Mayo, Rosalina Henares Espi, Francisco Sánchez-Madrid, Enrique Martín Gayo, Ildefonso Sánchez-Cerrillo, Ana Marcos Jimenez, Pedro Martínez-Fleta, Celia López-Sanz, Ligia Gabrie, Luciana del Campo Guerola, Reyes Tejedor, Rosa Carracedo Rodríguez
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundInterleukin 6 (IL6) levels and SARS-CoV-2 viremia have been correlated with COVID-19 severity. The association over time between them has not been assessed in a prospective cohort. Our aim was to evaluate the relationship between SARS-CoV-2
Externí odkaz:
https://doaj.org/article/2e8c5c8c3fe4433d9e6a941239aec30c
Autor:
Pedro Martínez-Fleta, Paula Vera-Tomé, María Jiménez-Fernández, Silvia Requena, Emilia Roy-Vallejo, Ancor Sanz-García, Marta Lozano-Prieto, Celia López-Sanz, Alicia Vara, Ángel Lancho-Sánchez, Enrique Martín-Gayo, Cecilia Muñoz-Calleja, Arantzazu Alfranca, Isidoro González-Álvaro, José María Galván-Román, Javier Aspa, Hortensia de la Fuente, Francisco Sánchez-Madrid
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Coronavirus Disease 2019 (COVID-19) pneumonia is a life-threatening infectious disease, especially for elderly patients with multiple comorbidities. Despite enormous efforts to understand its underlying etiopathogenic mechanisms, most of them remain
Externí odkaz:
https://doaj.org/article/1b20838174a343a6a6c1d5ad4202c9c0
Autor:
Julio Collazos, Pere Domingo, Nerio Fernández-Araujo, Elia Asensi-Díaz, Helem Vilchez-Rueda, Antonio Lalueza, Emilia Roy-Vallejo, Rosa Blanes, Manuel Raya-Cruz, Jaime Sanz-Cánovas, Arturo Artero, José-Manuel Ramos-Rincón, Carlos Dueñas-Gutiérrez, José Luis Lamas-Ferreiro, Víctor Asensi, Valproic Acid in COVID-19 Study Group
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262777 (2022)
BackgroundValproic acid (VPA) has shown beneficial effects in vitro against SARS-CoV-2 infection, but no study has analyzed its efficacy in the clinical setting.MethodsThis multicenter, retrospective study included 165 adult patients receiving VPA at
Externí odkaz:
https://doaj.org/article/f02585ec915c4415abe1a9f67ad1d733
Autor:
Ana Triguero-Martínez, Emilia Roy-Vallejo, Eva Gloria Tomero, Nuria Montes, Hortensia de la Fuente, Ana María Ortiz, Santos Castañeda, Amalia Lamana, Isidoro González-Álvaro
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 21, p 6313 (2022)
Galectin-1 (Gal1) plays a regulatory role in the immune system. We have recently validated that Gal1 serum (sGal1) levels are increased in rheumatoid arthritis (RA) patients compared to healthy donors (HDs); however, there is no information on Gal1 i
Externí odkaz:
https://doaj.org/article/ef4df27b61a64041b1e0823d6e7eb9f2
Autor:
Ana Triguero-Martínez, Emilia Roy-Vallejo, Nuria Montes, Hortensia de la Fuente, Ana María Ortiz, Santos Castañeda, Isidoro González-Álvaro, Amalia Lamana
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7181 (2022)
Galectin 1 (Gal1) exerts immunomodulatory effects leading to therapeutic effects in autoimmune animal models. Patients with rheumatoid arthritis have been reported to show higher Gal1 serum levels than the healthy population. Our study aimed to find
Externí odkaz:
https://doaj.org/article/9ccc438d35df41d893e6da4c907f19fc